Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17352768rdf:typepubmed:Citationlld:pubmed
pubmed-article:17352768lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:17352768lifeskim:mentionsumls-concept:C0021756lld:lifeskim
pubmed-article:17352768lifeskim:mentionsumls-concept:C0243009lld:lifeskim
pubmed-article:17352768lifeskim:mentionsumls-concept:C2698872lld:lifeskim
pubmed-article:17352768lifeskim:mentionsumls-concept:C1522577lld:lifeskim
pubmed-article:17352768lifeskim:mentionsumls-concept:C1561565lld:lifeskim
pubmed-article:17352768lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:17352768lifeskim:mentionsumls-concept:C0439231lld:lifeskim
pubmed-article:17352768lifeskim:mentionsumls-concept:C0439378lld:lifeskim
pubmed-article:17352768lifeskim:mentionsumls-concept:C1516050lld:lifeskim
pubmed-article:17352768lifeskim:mentionsumls-concept:C1552601lld:lifeskim
pubmed-article:17352768pubmed:issue2lld:pubmed
pubmed-article:17352768pubmed:dateCreated2007-3-13lld:pubmed
pubmed-article:17352768pubmed:abstractTextESPRIT is a randomized trial comparing the clinical impact of interleukin (IL)-2 plus antiretrovirals vs antiretrovirals alone. Identification of factors that influence the relationship between IL-2 and CD4 count recovery will enable better personalization of treatment with IL-2 in HIV-1-positive individuals. The IL-2 induction phase consists of three dosing cycles over 6-8 months (7.5 MIU twice a day, for 5 days every 8 weeks).lld:pubmed
pubmed-article:17352768pubmed:languageenglld:pubmed
pubmed-article:17352768pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17352768pubmed:citationSubsetIMlld:pubmed
pubmed-article:17352768pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17352768pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17352768pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17352768pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17352768pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17352768pubmed:statusMEDLINElld:pubmed
pubmed-article:17352768pubmed:monthMarlld:pubmed
pubmed-article:17352768pubmed:issn1464-2662lld:pubmed
pubmed-article:17352768pubmed:authorpubmed-author:GuoY EYElld:pubmed
pubmed-article:17352768pubmed:authorpubmed-author:PhillipsAndre...lld:pubmed
pubmed-article:17352768pubmed:authorpubmed-author:KlimasNancyNlld:pubmed
pubmed-article:17352768pubmed:authorpubmed-author:WeissLaurence...lld:pubmed
pubmed-article:17352768pubmed:authorpubmed-author:LundgrenJens...lld:pubmed
pubmed-article:17352768pubmed:authorpubmed-author:StaszewskiSch...lld:pubmed
pubmed-article:17352768pubmed:authorpubmed-author:GazzardBrianBlld:pubmed
pubmed-article:17352768pubmed:authorpubmed-author:NeatonJames...lld:pubmed
pubmed-article:17352768pubmed:authorpubmed-author:RuxrungthamKi...lld:pubmed
pubmed-article:17352768pubmed:authorpubmed-author:AntunesFranci...lld:pubmed
pubmed-article:17352768pubmed:authorpubmed-author:LossoMarceloMlld:pubmed
pubmed-article:17352768pubmed:authorpubmed-author:ESPRIT...lld:pubmed
pubmed-article:17352768pubmed:authorpubmed-author:DaveyRickRlld:pubmed
pubmed-article:17352768pubmed:authorpubmed-author:LabriolaAnnAlld:pubmed
pubmed-article:17352768pubmed:issnTypePrintlld:pubmed
pubmed-article:17352768pubmed:volume8lld:pubmed
pubmed-article:17352768pubmed:ownerNLMlld:pubmed
pubmed-article:17352768pubmed:authorsCompleteYlld:pubmed
pubmed-article:17352768pubmed:pagination112-23lld:pubmed
pubmed-article:17352768pubmed:meshHeadingpubmed-meshheading:17352768...lld:pubmed
pubmed-article:17352768pubmed:meshHeadingpubmed-meshheading:17352768...lld:pubmed
pubmed-article:17352768pubmed:meshHeadingpubmed-meshheading:17352768...lld:pubmed
pubmed-article:17352768pubmed:meshHeadingpubmed-meshheading:17352768...lld:pubmed
pubmed-article:17352768pubmed:meshHeadingpubmed-meshheading:17352768...lld:pubmed
pubmed-article:17352768pubmed:meshHeadingpubmed-meshheading:17352768...lld:pubmed
pubmed-article:17352768pubmed:meshHeadingpubmed-meshheading:17352768...lld:pubmed
pubmed-article:17352768pubmed:meshHeadingpubmed-meshheading:17352768...lld:pubmed
pubmed-article:17352768pubmed:meshHeadingpubmed-meshheading:17352768...lld:pubmed
pubmed-article:17352768pubmed:meshHeadingpubmed-meshheading:17352768...lld:pubmed
pubmed-article:17352768pubmed:meshHeadingpubmed-meshheading:17352768...lld:pubmed
pubmed-article:17352768pubmed:meshHeadingpubmed-meshheading:17352768...lld:pubmed
pubmed-article:17352768pubmed:meshHeadingpubmed-meshheading:17352768...lld:pubmed
pubmed-article:17352768pubmed:meshHeadingpubmed-meshheading:17352768...lld:pubmed
pubmed-article:17352768pubmed:meshHeadingpubmed-meshheading:17352768...lld:pubmed
pubmed-article:17352768pubmed:year2007lld:pubmed
pubmed-article:17352768pubmed:articleTitlePredictors of CD4 count change over 8 months of follow up in HIV-1-infected patients with a CD4 count>or=300 cells/microL who were assigned to 7.5 MIU interleukin-2.lld:pubmed
pubmed-article:17352768pubmed:affiliationHvidovre University Hospital, DK-2650 Hvidovre, Denmark. z.fox@pcps.ucl.ac.uklld:pubmed
pubmed-article:17352768pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17352768pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:17352768pubmed:publicationTypeMulticenter Studylld:pubmed
pubmed-article:17352768pubmed:publicationTypeClinical Trial, Phase IIIlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17352768lld:pubmed